A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis. - Suppr | 超能文献

A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.

作者信息

Okubo M, Aoyama Y, Harada K, Fukawa M, Tsukada T, Mokuno H, Yamada N, Murase T

出版信息

Atherosclerosis. 1998 Sep;140(1):187-90. doi: 10.1016/s0021-9150(98)00121-x.

DOI:10.1016/s0021-9150(98)00121-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.

Atherosclerosis. 1998 Sep;140(1):187-90. doi: 10.1016/s0021-9150(98)00121-x.

2

Dyslipidemia and accelerated atherosclerosis.

Hosp Pract (Off Ed). 1988 May 30;23(5A):41-50.

3

Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.

Metabolism. 1990 Nov;39(11):1196-9. doi: 10.1016/0026-0495(90)90094-s.

4

Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.载脂蛋白E基因多态性对日本血浆脂质和载脂蛋白水平的影响以及载脂蛋白E表型E2/2所致Ⅲ型高脂蛋白血症的临床特征

Atherosclerosis. 1988 Jan;69(1):81-8. doi: 10.1016/0021-9150(88)90291-2.

5

[From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].[从基因到疾病；载脂蛋白E2与家族性异常β脂蛋白血症]

Ned Tijdschr Geneeskd. 2003 Jan 25;147(4):157-9.

6

Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote.由载脂蛋白E2/E2纯合子的III型高脂蛋白血症引起的妊娠期高脂血症性胰腺炎。

Pancreas. 2009 Aug;38(6):716-7. doi: 10.1097/MPA.0b013e3181ac6dc1.

7

Simple precipitation-based method for the screening of type III hyperlipoproteinemia.用于筛查III型高脂蛋白血症的基于简单沉淀的方法。

Clin Chem. 1999 Jun;45(6 Pt 1):909-11.

8

Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.台湾人群中的载脂蛋白ε2/3基因型与Ⅲ型高脂蛋白血症

Clin Chim Acta. 2003 Apr;330(1-2):173-8. doi: 10.1016/s0009-8981(03)00050-0.

9

Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.法裔加拿大高脂血症载脂蛋白E2/2受试者群体中载脂蛋白E2（精氨酸158----半胱氨酸）的频率。用合成寡核苷酸探针进行测定。

Arteriosclerosis. 1989 Jan-Feb;9(1):50-7. doi: 10.1161/01.atv.9.1.50.

10

Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.新型突变体载脂蛋白E1名古屋（Arg142Ser）和载脂蛋白E2（Arg158Cys）的复合杂合子，伴有严重的III型高脂蛋白血症和家族性高胆固醇血症。

J Atheroscler Thromb. 2014;21(9):983-8. doi: 10.5551/jat.21394. Epub 2014 Jun 20.

引用本文的文献

1

Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.载脂蛋白E变异体的影响：天然存在的变异体与临床特征综述

J Atheroscler Thromb. 2025 Mar 1;32(3):281-303. doi: 10.5551/jat.65393. Epub 2025 Jan 8.

2

Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.建立家族性载脂蛋白 E 代谢障碍与 APOE 基因遗传变异之间的关系。

Clin Genet. 2022 Oct;102(4):253-261. doi: 10.1111/cge.14185. Epub 2022 Aug 22.

3

Role of apolipoprotein E in neurodegenerative diseases.载脂蛋白E在神经退行性疾病中的作用。

Neuropsychiatr Dis Treat. 2015 Jul 16;11:1723-37. doi: 10.2147/NDT.S84266. eCollection 2015.